Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A prospective, randomized, double-masked study evaluating the ocular efficacy and safety of
two doses of the EYP-1901 intravitreal insert compared to sham